Frontiers in immunology · 2026
Laminaria japonica polysaccharide mitigates acute neuroinflammation in cerebral ischemia-reperfusion injury through Csf3-modulated pathways.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Guan Tangming, Chen Siyu, Jiang Dongbo, Cai Weiming, Chen Huayan, Wang Yan, Wu Kefeng, Zhou Xin
Аннотация
INTRODUCTION: Microglial hyperactivation-driven neuroinflammation is a major driver of secondary brain injury following cerebral ischemia/reperfusion (I/R), yet effective therapies targeting this pathological process remain limited. Marine-derived sulfated polysaccharides have emerged as promising anti-inflammatory agents, but the therapeutic potential and mechanisms of Laminaria japonica polysaccharide (LJP) in cerebral I/R injury are poorly understood.
METHODS: LJP was isolated from Laminaria japonica and structurally characterized via high-performance gel permeation chromatography (HPGPC), Fourier-transform infrared (FT-IR) spectroscopy, and ion chromatography. Its neuroprotective effects were evaluated in a mouse model of transient middle cerebral artery occlusion (tMCAO), with assessments of infarct volume, neurological function, and neuroinflammatory markers. Cross-species transcriptomic analysis identified potential targets, which were validated through in vivo and in vitro functional assays (rescue experiments with recombinant Csf3 and neutralization assays with Csf3-specific antibodies).
RESULTS: Structural characterization confirmed LJP is enriched in fucose, galacturonic acid, glucuronic acid, and sulfate groups. In tMCAO mice, LJP administration reduced infarct volume, improved neurological function, and suppressed microglial pro-inflammatory polarization, accompanied by decreased levels of interleukin-1b (IL-1b), tumor necrosis factor-α (TNFα), and interleukin-6 (IL-6). Transcriptomic analysis identified granulocyte colony-stimulating factor (Csf3/G-CSF) as a potential LJP-regulated mediator. Recombinant Csf3 partially reversed LJP's protective effects, while Csf3-specific antibodies failed to enhance LJP's anti-inflammatory benefits, suggesting Csf3 as an important contributory mechanism.
DISCUSSION: These findings demonstrate that LJP mitigates acute neuroinflammation post-I/R at least partly through Csf3 suppression, highlighting its promise as a novel phytotherapeutic agent for ischemic stroke.
METHODS: LJP was isolated from Laminaria japonica and structurally characterized via high-performance gel permeation chromatography (HPGPC), Fourier-transform infrared (FT-IR) spectroscopy, and ion chromatography. Its neuroprotective effects were evaluated in a mouse model of transient middle cerebral artery occlusion (tMCAO), with assessments of infarct volume, neurological function, and neuroinflammatory markers. Cross-species transcriptomic analysis identified potential targets, which were validated through in vivo and in vitro functional assays (rescue experiments with recombinant Csf3 and neutralization assays with Csf3-specific antibodies).
RESULTS: Structural characterization confirmed LJP is enriched in fucose, galacturonic acid, glucuronic acid, and sulfate groups. In tMCAO mice, LJP administration reduced infarct volume, improved neurological function, and suppressed microglial pro-inflammatory polarization, accompanied by decreased levels of interleukin-1b (IL-1b), tumor necrosis factor-α (TNFα), and interleukin-6 (IL-6). Transcriptomic analysis identified granulocyte colony-stimulating factor (Csf3/G-CSF) as a potential LJP-regulated mediator. Recombinant Csf3 partially reversed LJP's protective effects, while Csf3-specific antibodies failed to enhance LJP's anti-inflammatory benefits, suggesting Csf3 as an important contributory mechanism.
DISCUSSION: These findings demonstrate that LJP mitigates acute neuroinflammation post-I/R at least partly through Csf3 suppression, highlighting its promise as a novel phytotherapeutic agent for ischemic stroke.